2.78
0.02 (0.54%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Packaged Foods (US) | Bearish | Bearish |
| Packaged Foods (Global) | Bearish | Mixed | |
| Stock | ChromaDex Corporation | Mixed | Bullish |
Stockmoo Score
|
ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment. |
|
| Sector | Consumer Defensive |
| Industry | Packaged Foods |
| Investment Style | Small Growth |
| 52 Weeks Range | ||
| Median | 6.00 (116.22%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| HC Wainwright & Co. | 09 Aug 2024 | 6.00 (116.22%) | Buy | 2.75 |
| 15 Jul 2024 | 6.00 (116.22%) | Buy | 2.77 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |